Acromegaly secondary to growth hormone-releasing hormone secreted by an incidentally discovered pheochromocytoma

Endocrine Pathology

Volumn 18, Issue 1, 2007, Pages 46-52

  Vieira Neto, L ^a   Taboada, G F ^a   Correa L L ^a   Polo, J ^a   Nascimento, A F ^b   Chimelli, L ^a   Rumilla, K ^c   Gadelha, M R ^a,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MAYO CLINIC   (United States)

^d NONE   (Brazil)

Author keywords

Acromegaly; GHRH; Pheochromocytoma

Indexed keywords

CATECHOLAMINE; GROWTH HORMONE; PROTEIN RET;

ACROMEGALY; ADRENALECTOMY; ADULT; ARTICLE; CASE REPORT; CATECHOLAMINE URINE LEVEL; CLINICAL FEATURE; DIAGNOSTIC IMAGING; GENETIC ANALYSIS; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TISSUE SECTION;

ACROMEGALY; ADRENAL GLAND NEOPLASMS; ADULT; GROWTH HORMONE-RELEASING HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PHEOCHROMOCYTOMA; SELLA TURCICA; TREATMENT OUTCOME;

EID: 34548357162     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-007-0006-8     Document Type: Article

References (46)

1. Taboada GF, van Haute FR, Correa LL, et al. Etiologic aspects and management of acromegaly. Arq Bras Endocrinol Metabol 49:626-40, 2005.
2. Melmed S, Ezrin C, Kovacs K, et al. Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med 312:9-17, 1985.
3. Beuschlein F, Strasburger CJ, Siegerstetter V, et al. Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. N Engl J Méd 342:1871-6, 2000.
4. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-73, 1988.
5. Thorner MO, Frohman LA, Leong DA, et al. Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 59:846-9, 1984.
6. Faglia G, Arosio M, Bazzoni N. Ectopic acromegaly. Endocrinol Metab Clin North Am 21:575-95, 1992.
7. Reuters VS, Dias EMR, Pupo MRSR, et al. Acromegaly secondary to ectopic growth hormone-releasing hormone-secreting bronchial carcinoid cured after pneumectomy. Endocrinologist 13:376-9, 2003.
8. Scheithauer BW, Carpenter PC, Bloch B, et al. Ectopic secretion of a growth hormone-releasing factor. Report of a case of acromegaly with bronchial carcinoid tumor. Am J Med 76:605-16, 1984.
9. Caron P, Guittard J, Trouillas J, et al. Acromegalie et tumeur carcinoide bronchique. A propos d'une observation. Ann d'Endocrinol 53:158-61, 1992.
10. Ezzat S, Asa SL, Stefaneanu L, et al. Somatotroph hyperplasia without pituitary adenoma associated with a longstanding growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 78:555-60, 1994.
11. Sanno N, Teramoto A, Osamura RY, et al. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. J Clin Endocrinol Metab 82:2731-2, 1997.
12. Shintani Y, Yoshimoto K, Horie H, et al. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features. Endocr J 42:331-40, 1995.
13. Zimmerman D, Young WF Jr, Ebersold MJ, et al. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 76:216-22, 1993.
14. Iversen K. Acromegaly associated with phaeochromocytoma. Acta Med Scand 142:1-5, 1952.
15. Kahn MT, Mullen DA. Pheochromocytoma without hypertension - report of a patient with acromegaly. JAMA 188:74-5, 1964.
16. German WJ, Flanigan S. Pituitary adenomas: a follow-up study of the Cushing series. Clin Neurosurg 10:72-81, 1964.
17. O'Higgins NJ, Cullen MJ, Heffernan AG. A case of acromegaly and phaeochromocytoma. J Ir Med Assoc 60:213-6, 1967.
18. Miller GL, Wynn J. Acromegaly, pheochromocytoma, toxic goiter, diabetes mellitus, and endometriosis. Arch Intern Med 127:299-303, 1971.
19. Farhi F, Dikman SH, Lawson W, Cobin RH, Zak FG. Paragangliomatosis associated with multiple endocrine adenomas. Arch Pathol Lab Med 100:495-8, 1976.
20. Kodowaki S, Baba Y, Kakita T, et al. A case of acromegaly associated with pheochromocytoma. Saishin-Igaku 31:1402-9, 1976.
21. Manger WM, Gifford RW. Pheochromocytoma. New York: Springer-Velag, 284-6; 1977.
22. Anderson RJ, Lufkin EG, Sizemore GW, et al. Acromegaly and pituitary adenoma with phaeochromocytoma: a variant of multiple endocrine neoplasia. Clin Endocrinol 14:605-12, 1981.
23. Myers JH, Eversman JJ. Acromegaly, hyperparathyroidism, and pheochromocytoma in the same patient. A multiple endocrine disorder. Arch Intern Med 141:1521-2, 1981.
24. Roth KA, Wilson DM, Eberwine J, et al. Acromegaly and pheochromocytoma: a multiple endocrine syndrome caused by a plurihormonal adrenal medullary tumor. J Clin Endocrinol Metab 63:1421-6, 1986.
25. Saito H, Sano T, Yamasaki R, Mitsuhashi S, Hosoi E, Saito S. Demonstration of biological activity of a growth hormone-releasing hormone-like substance produced by a pheochromocytoma. Acta Endocrinol 129:246-50, 1993.
26. Teh BT, Hansen J, Svensson PJ, Hartley L. Bilateral recurrent phaeochromocytoma associated with a growth hormone-secreting pituitary tumour. Br J Surg 83:1132, 1996.
27. Baughan J, de Gara C, Morrish D. A rare association between acromegaly and pheochromocytoma. Am J Surg 182:185-7, 2001.
28. Sleilati GG, Kovacs KT, Honasoge M. Acromegaly and pheochromocytoma: report of a rare coexistence. Endocr Pract 8:54-60, 2002.
29. Breckenridge SM, Hamrahian AH, Faiman C, Suh J, Prayson R, Mayberg M. Coexistence of a pituitary macroadenoma and pheochromocytoma - a case report and review of the literature. Pituitary 6:221-5, 2003.
30. Frohman L, Szabo M, Berelowitz M, et al. Partial purification and characterization of a peptide with growth hormone-releasing activity from extra pituitary tumors in patients with acromegaly. J Clin Invest 65:43-54, 1980.
31. Berger G, Trouillas J, Bloch B, et al. Multihormonal carcinoid tumor of the pancreas secreting growth hormone-releasing factor as a cause of acromegaly. Cancer 54:2097-108, 1984.
32. Vance ML, Kaiser DL, Evans WS, et al. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion. J Clin Invest 75:1584-90, 1985.
33. Ch'ng JLC, Chritofides ND, Kraezlin ME, et al. Growth hormone secretion dynamics in a patient with ectopic growth hormone-releasing factor production. Am J Med 79:135-8, 1985.
34. Popovic V, Micic D, Damjanovic S, et al. Discordance between growth hormone responses after growth hormone-releasing hormone (GHRH) and insulin hypoglycemia in ectopic GHRH syndrome. Endocrinol Exp 24:167-73, 1990.
35. Barkan AL, Shenker Y, Grekin RJ, et al. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab 63:1057-64, 1986.
36. Wilson DM, Ceda GP, Bostwick DG, et al. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. J Clin Endocrinol Metab 59:1002-5, 1984.
37. Horvath E, Kovacs K, Scheithauer BW. Pituitary hyperplasia. Pituitary 1:169-80, 1999.
38. Reichlin S. Functional aspects of endocrine neoplasms. In: Kovacs K, Asa SL, editors. Functional endocrine pathology. Boston: Blackwell Scientific Publications, p 898, 1991.
39. Thorner MO, Perryman RL, Cronin MJ, et al. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 70:965-77, 1982.
40. Asa S, Kovacs K, Stefaneanu L, et al. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131:2083-9, 1992.
41. Lloyd RV, Jin L, Chang A, et al. Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. Am J Pathol 141:895-906, 1992.
42. Asa SL, Scheithauer BW, Bilbao JM, et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 58:796-803, 1984.
43. Losa M, von Werder K. Pathophysiology and clinical aspects of the ectopic GH-releasing hormone syndrome. Clin Endocrinol 47:123-35, 1997.
44. Morel O, Giraud P, Bernier MO, et al. Ectopic acromegaly: localization of the pituitary growth hormone-releasing hormone producing tumor by In-111 pentetreotide scintigraphy and report of two cases. Clin Nucl Med 29:841-3, 2004.
45. Sasaki A, Yumita S, Kimura S, et al. Immunoreactive corticotropin- releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma. J Clin Endocrinol Metab 70:996-9, 1990.
46. Wimalawansa SJ. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239, 1997.